| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 04/03/2013 | CN102309001B Food composition and medicinal composition of lactobacillus strain for treating allergy |
| 04/03/2013 | CN102266393B External application medicament for treating allergic rhinitis and preparation method thereof |
| 04/03/2013 | CN102258593B Chinese medicinal composition for adjuvant treatment of tumors and preparation method and application thereof |
| 04/03/2013 | CN102258543B Method for processing lucid ganoderma |
| 04/03/2013 | CN102133281B Edible fungi health care pill |
| 04/03/2013 | CN102127054B 3-(substituted dihydroisoindol-2-yl)-2,6-piperidinedione polymorph and pharmaceutical composite |
| 04/03/2013 | CN102086195B Dasatinib polymorphic substance as well as preparation method and medicinal composition thereof |
| 04/03/2013 | CN102086182B Petasites tatewakianus Kitam. extract as well as preparation method and application thereof |
| 04/03/2013 | CN102048803B Composition with fatigue resistance and immune system improving function, and preparation method and application thereof |
| 04/03/2013 | CN101987844B Method for synthesizing 4-(4-chlorobenzyl)-2-(hexahydro-1-methyl-1H-diazepoxide-4-radical)-1-(2H)-phthalizine hydrochloride |
| 04/03/2013 | CN101874826B Granulose rabdosia rubescens compound preparation and preparation method thereof |
| 04/03/2013 | CN101857594B Tetrahydropyridoindole compounds, and preparation method and application thereof |
| 04/03/2013 | CN101631555B Prophylactic agent for autoimmune disease |
| 04/03/2013 | CN101444303B Dendrobium kudzu eucommia bark functional food |
| 04/03/2013 | CN101316587B 取代的吡唑化合物 Substituted pyrazole compound |
| 04/03/2013 | CN101313063B Cancer-rejection antigen peptide derived from glypican-3 (GPC3) for use in HLA-A2-positive patient and pharmaceutical comprising the antigen |
| 04/02/2013 | US8410266 2,4-pyrimidinediamine compounds and their uses |
| 04/02/2013 | US8410174 Method for treating arthritis |
| 04/02/2013 | US8410110 9-(piperazinylalkyl) carbazoles as Bax-modulators |
| 04/02/2013 | US8410053 Methods for treating autoimmune disorders, and reagents related thereto |
| 04/02/2013 | US8409588 Recombinant foot and mouth disease vaccine |
| 04/02/2013 | US8409578 Methods for treating bone loss with antibodies to OPGL |
| 04/02/2013 | US8409575 Antibodies specific for amyloid beta protofibril |
| 04/02/2013 | US8409572 Monoclonal antibodies with enhanced ADCC function |
| 04/02/2013 | CA2772962C Method of preparing plant-derived vlps |
| 04/02/2013 | CA2588410C 2-methylene-19-nor-1.alpha.-hydroxy-17-ene-homopregnacalciferol and its uses |
| 04/02/2013 | CA2581110C Peptides and apl-type derivatives of hsp60 and pharmaceutical compositions |
| 04/02/2013 | CA2550843C Novel phenylalanine derivatives |
| 04/02/2013 | CA2533594C Compounds for inflammation and immune-related uses |
| 04/02/2013 | CA2532799C Human antibody molecules for il-13 |
| 04/02/2013 | CA2512108C Certain aminoalkyl glucosaminide phosphate compounds and their use |
| 04/02/2013 | CA2475633C Heteroaryl compounds useful as inhibitors of gsk-3 |
| 04/02/2013 | CA2472647C Mammal prolactin variants |
| 04/02/2013 | CA2460392C Recombinant allergen with reduced ige binding but undiminished t-cell antigenicity |
| 04/02/2013 | CA2457611C Novel molecular target for neurotoxicity |
| 04/02/2013 | CA2396212C Recombinant antibodies to human interleukin-1 beta |
| 04/02/2013 | CA2201282C Viral material and nucleotide fragments associated with multiple sclerosis useful for diagnostic, preventive and therapeutic purposes |
| 03/29/2013 | CA2849336A1 Cyanomethylpyrazole carboxamides as janus kinase inhibitors |
| 03/28/2013 | WO2013043960A1 Compounds useful as inhibitors of choline kinase |
| 03/28/2013 | WO2013043933A2 Cd27l antigen binding proteins |
| 03/28/2013 | WO2013043826A1 Tricyclic compounds useful as protein kinase inhibitors |
| 03/28/2013 | WO2013043085A1 Pharmaceutical substance (variants) and compositions based thereon which exhibit modulatory activity with a commensurate effect |
| 03/28/2013 | WO2013041732A1 Total synthesis and immunological evaluation of saccharide moieties of the lipopolysaccharide from neisseria meningitidis |
| 03/28/2013 | WO2013041652A1 Morpholino substituted urea or carbamate derivatives as mtor inhibitors |
| 03/28/2013 | WO2013041605A1 Pyrazolo[4,3-c]pyridine derivatives as kinase inhibitors |
| 03/28/2013 | WO2013041497A1 Substituted n- [1-cyano-2- (phenyl) ethyl] -2-azabicyclo [2.2.1] heptane-3-carboxamide inhibitors of cathepsin c |
| 03/28/2013 | WO2013041407A1 Hydroxamic acids as hdac6 inhibitors |
| 03/28/2013 | WO2013040863A1 Cycloalkylnitrile pyrazole carboxamides as janus kinase inhibitors |
| 03/28/2013 | WO2013040801A1 Hydroxamic acid compound containing quinolyl and preparation method thereof, and pharmaceutical composition containing this compound and use thereof |
| 03/28/2013 | WO2013040649A1 Therapeutics using adipose cells and cell secretions |
| 03/28/2013 | WO2013016720A3 Novel substituted biarylheterocycle derivatives as protein kinase inhibitors for the treatment of cancer and other diseases |
| 03/28/2013 | WO2013012915A9 Heterocyclic compounds and uses thereof |
| 03/28/2013 | WO2012177075A3 Composition containing antibiotics and lysophosphatidylcholine for boosting immunity or treatment of bacterial infections |
| 03/28/2013 | WO2012072268A8 Anti cd4 antibodies to prevent in particular graft -versus - host - disease (gvhd) |
| 03/28/2013 | WO2011006935A3 Tetrazole derivatives |
| 03/28/2013 | US20130079514 "omega-aminoalkylamides of r-2-aryl-propionic acids as inhibitors of the chemotaxis of polymorphonucleate and mononucleate cells" |
| 03/28/2013 | US20130079377 Aryl or N-heteroaryl Substituted Methanesulfonamide Derivatives as Vanilloid Receptor Ligands |
| 03/28/2013 | US20130079373 Substituted Methanesulfonamide Derivatives as Vanilloid Receptor Ligands |
| 03/28/2013 | US20130079337 Pyrazoloquinolinone derivatives, preparation thereof and therapeutic use thereof |
| 03/28/2013 | US20130079321 Pyrazol-4-yl-heterocyclyl-carboxamide compounds and methods of use |
| 03/28/2013 | US20130079317 Methods for treatment of diseases |
| 03/28/2013 | US20130078280 Cyclosporine analogue mixtures and their use as immunomodulating agents |
| 03/28/2013 | US20130078266 Immunosuppression By Blocking T Cell Co-Stimulation Signal 2 (B7/CD28 Interaction) |
| 03/28/2013 | US20130078263 Anti-HLA-DR Antibodies Suppress Allogeneic and Xenogeneic Immune Responses to Organ Transplants |
| 03/28/2013 | US20130078259 Method of diagnosing and preventing pneumococcal diseases using pneumococcal neuraminidases |
| 03/28/2013 | US20130078237 Cd27l antigen binding proteins |
| 03/28/2013 | CA2858033A1 Quinolyl-containing hydroxamic acid compound and preparation method thereof, and pharmaceutical composition containing this compound and use thereof |
| 03/28/2013 | CA2849822A1 Novel influenza hemagglutinin protein-based vaccines |
| 03/28/2013 | CA2849711A1 Compound having modulatory activity with a commensurate effect, pharmaceutical substance (variants), application of pharmaceutical substance, pharmaceutical and parapharmaceuticalformulation (variants), method of preparation of pharmaceutical compositions |
| 03/28/2013 | CA2849442A1 Compounds useful as inhibitors of choline kinase |
| 03/28/2013 | CA2849434A1 Influenza virus vaccines and uses thereof |
| 03/28/2013 | CA2849409A1 Anti-tumor necrosis factor-alpha agents and uses thereof |
| 03/28/2013 | CA2849357A1 Acyclic cyanoethylpyrazoles as janus kinase inhibitors |
| 03/28/2013 | CA2849340A1 Pyrazolo[4,3-c]pyridine derivatives as kinase inhibitors |
| 03/28/2013 | CA2849318A1 Cd27l antigen binding proteins |
| 03/28/2013 | CA2849255A1 A composition and method for treating an autoimmune disease |
| 03/28/2013 | CA2849189A1 Morpholino substituted urea or carbamate derivatives as mtor inhibitors |
| 03/28/2013 | CA2849168A1 Cycloalkylnitrile pyrazole carboxamides as janus kinase inhibitors |
| 03/28/2013 | CA2848929A1 Substituted n- [1-cyano-2- (phenyl) ethyl] -2-azabicyclo [2.2.1] heptane-3-carboxamide inhibitors of cathepsin c |
| 03/28/2013 | CA2846062A1 Shigella-derived vector and methods of using the same |
| 03/28/2013 | CA2845409A1 Imidazopyridine compounds, compositions and methods of use |
| 03/28/2013 | CA2843019A1 Anti-hla-dr antibodies suppress allogeneic and xenogeneic immune responses to organ transplants |
| 03/27/2013 | EP2573121A1 Antibodies that bind il-4 and/or il-13 and their uses |
| 03/27/2013 | EP2572734A2 Cytokine-based fusion proteins for treatment of immune disorders |
| 03/27/2013 | EP2571979A1 Bacterial ribonucleic acid cell wall compositions and methods of making and using them |
| 03/27/2013 | EP2571884A2 Mtor selective kinase inhibitors |
| 03/27/2013 | EP2571881A1 Pyrrolopyrazine derivatives as syk and jak inhibitors |
| 03/27/2013 | EP2571880A1 Pyrrolo [2, 3 - b]pyrazine - 7 - carboxamide derivatives and their use as jak and syk inhibitors |
| 03/27/2013 | EP2571870A1 Ccr2 antagonists and uses thereof |
| 03/27/2013 | EP2571516A1 Il-12 formulations for enhancing hematopoiesis |
| 03/27/2013 | CN1856568B Fermentation and culture method, fermented plant extract, fermented plant extract powder and composition containing the fermented plant extract |
| 03/27/2013 | CN1370083B Ninovasive genetic immnization, expression products therefrom, and uses thereof |
| 03/27/2013 | CN103003427A Novel nucleic acid having adjuvant activity and use thereof |
| 03/27/2013 | CN103003306A Antibodies |
| 03/27/2013 | CN103003299A Antagonists for the prevention or treatment of inflammatory bowel disease, and more particularly of Crohn's disease |
| 03/27/2013 | CN103003281A Pyrrolo [2, 3 - b] pyrazine - 7 - carboxamide derivatives and their use as jak and syk inhibitors |
| 03/27/2013 | CN103003273A Pyrazolopyridine kinase inhibitors |
| 03/27/2013 | CN103003234A N-hydroxyformamide derivative and pharmaceutical containing same |
| 03/27/2013 | CN103002923A Stabilized fibronectin domain compositions, methods and uses |
| 03/27/2013 | CN103002913A Compositions and methods for targeting type I interferon producing cells |